Orchestra BioMed Holdings (OBIO)
NASDAQ:OBIO
US Market
Holding OBIO?
Track your performance easily

Orchestra BioMed Holdings (OBIO) Ownership - Who Owns Orchestra BioMed Holdings?

56 Followers

Orchestra BioMed Holdings (OBIO) Ownership Overview

11.76%6.86%0.04%5.97%75.38%
11.76% Insiders
0.04% Other Institutional Investors
5.97% ETFs
75.38% Public Companies and
Individual Investors
The ownership structure of Orchestra BioMed Holdings (OBIO) stock is a mix of institutional, retail, and individual investors. Approximately 12.86% of the company’s stock is owned by Institutional Investors, 11.76% is owned by Insiders, and 75.38% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 26, 2024
David Hochman
Ceo And Chairperson,director
xxxxxxxxxxxxx
$47905
Sep 10, 2024
Eric Fain
Director
xxxxxxxxxxxxx
$30666
Sep 10, 2024
Darren Sherman
President And Coo,director
xxxxxxxxxxxxx
$73946
Sep 06, 2024
Darren Sherman
President And Coo,director
xxxxxxxxxxxxx
$120955

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,545,881Institution6.73%15,860,839
1,705,705Insider4.51%10,626,542
1,239,396Institution3.28%7,721,437
1,112,731Institution2.94%6,932,314
914,640Insider2.42%5,698,207
799,381Institution2.11%4,980,144
765,787Insider2.02%4,770,853
378,412Institution1.00%2,357,507
378,363Insider1.00%2,357,201
307,859Insider0.81%1,917,962

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,112,731Institution2.94%6,932,314
378,412Institution1.00%2,357,507
262,308Institution0.69%1,634,179
257,651Institution0.68%1,605,166
254,106Institution0.67%1,583,080
113,365Institution0.30%706,264
67,293Institution0.18%419,235
43,445Institution0.11%270,662
25,094Institution0.07%156,336
19,629Institution0.05%122,289

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
698,140Institution1.85%3,588,440
519,248Institution1.37%2,835,094
414,591Institution1.10%2,130,998
131,546Institution0.35%718,241
129,857Institution0.34%686,944
106,671Institution0.28%548,289
94,413Institution0.25%515,495
54,174Institution0.14%295,790
20,101Institution0.05%106,334
12,624Institution0.03%66,781

FAQ

Who Owns Orchestra BioMed Holdings (OBIO)?
According to the latest TipRanks data, approximately 0.04% of the company's stock is held by institutional investors, 11.76% is held by insiders, and 75.38% is held by retail investors.
    What percentage of Orchestra BioMed Holdings (OBIO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.04% of Orchestra BioMed Holdings (OBIO) stock is held by institutional investors.
      What percentage of Orchestra BioMed Holdings (OBIO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 75.38% of Orchestra BioMed Holdings (OBIO) stock is held by retail investors.
        Who owns the most shares of Orchestra BioMed Holdings (OBIO)?
        Joseph Edelman owns the most shares of Orchestra BioMed Holdings (OBIO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis